FTC wants more information on Novo's $16.5B deal to boost Wegovy production
In February, Novo Nordisk agreed to buy Catalent for $16.5 billion. The Federal Trade Commission has since requested more information from the companies as it reviews the deal, The Wall Street Journal reported May 3. This marks the agency's second …